RECOMMENDATIONS Expand Access for GLP-1 Therapies Reform the Patent System: The patent system has been infected by the financialized business model of the pharmaceutical industry
Sources Novo Nordisk's Wegovy pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America Novo Nordisk January 5, 2026 Starter Dose of Wegovy now Available as a Daily Pill Instead of Weekly Injection CNN Health January 5, 2026
This kind of progress is unprecedented in the world of weight loss drugs
Transdermal estrogen also carries additional benefits independent of GLP-1 compatibility
The plotter shows in stark visual terms that you were only at 50-60% of steady state
Tirzepatide Maintenance Dose After Weight Loss The recommended tirzepatide doses for maintenance of weight loss are 5 mg, 10 mg, or 15 mg weekly, depending on a persons response